{"transactions":[{"id":741682,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:10:03.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 9, 2027 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":5000,"derivative":{"exercise_price":4.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-267533","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312526267533/ownership.xml","form_type":"4"}},{"id":967511,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":6.4,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967510,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reporting person agreed to cancellation of an option granted on May 27, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":1100,"derivative":{"exercise_price":5.44,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967509,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.364,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967508,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1100,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reporting person agreed to cancellation of an option granted on June 12, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1100,"derivative":{"exercise_price":5.44,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967507,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":32.6,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967506,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on June 12, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1250,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967505,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":39.8,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967504,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on June 10, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1250,"derivative":{"exercise_price":5.44,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967503,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":60.6,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":1810},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967502,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on March 24, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1810,"derivative":{"exercise_price":5.44,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":1810},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967501,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on November 17, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":180.2,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":1393},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":967500,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-12-16T22:13:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":1393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on November 17, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1393,"derivative":{"exercise_price":5.44,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":1393},"source":{"system":"sec-edgar","filing":"0001193125-25-321150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000119312525321150/ownership.xml","form_type":"4"}},{"id":1095132,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:05:27.000Z","date":"2025-05-27","kind":"grant","planned":false,"acquired":true,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 6, 2025, the Company effected a 1-for-20 reverse stock split of its common stock. All share and exercise price amounts reported herein reflect the reverse stock split. Prior to the reverse stock split, the reporting person was granted options to purchase 22,000 shares at an exercise price of $0.3200 per share."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 6, 2025, the Company effected a 1-for-20 reverse stock split of its common stock. All share and exercise price amounts reported herein reflect the reverse stock split. Prior to the reverse stock split, the reporting person was granted options to purchase 22,000 shares at an exercise price of $0.3200 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On June 6, 2025, the Company effected a 1-for-20 reverse stock split of its common stock. All share and exercise price amounts reported herein reflect the reverse stock split. Prior to the reverse stock split, the reporting person was granted options to purchase 22,000 shares at an exercise price of $0.3200 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 6, 2025, the Company effected a 1-for-20 reverse stock split of its common stock. All share and exercise price amounts reported herein reflect the reverse stock split. Prior to the reverse stock split, the reporting person was granted options to purchase 22,000 shares at an exercise price of $0.3200 per share."}],"balance_after":1100,"derivative":{"exercise_price":6.4,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":1100},"source":{"system":"sec-edgar","filing":"0000950170-25-092937","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000095017025092937/ownership.xml","form_type":"4"}},{"id":1478939,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:56:12.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 12, 2025 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":22000,"derivative":{"exercise_price":0.7682,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000950170-24-073898","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000095017024073898/ownership.xml","form_type":"4"}},{"id":1855889,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-14T21:19:49.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of June 12, 2024 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":1.63,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-037113","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000120919123037113/doc4.xml","form_type":"4"}},{"id":2147162,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-03T20:30:26.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable on September 30, 2023."}],"balance_after":13750,"derivative":{"exercise_price":2.16,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001493152-22-027434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1415015/000149315222027434/ownership.xml","form_type":"4"}},{"id":2235884,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T22:24:27.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest on the one-year anniversary of June 10, 2022 (the \"Vesting Commencement Date\") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":1.99,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-036086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000120919122036086/doc4.xml","form_type":"4"}},{"id":2316627,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-28T19:24:36.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":14071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest on the one-year anniversary of June 10, 2021 (the \"Vesting Commencement Date\") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":14071,"derivative":{"exercise_price":3.03,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":14071},"source":{"system":"sec-edgar","filing":"0000899243-22-012466","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000089924322012466/doc4.xml","form_type":"4"}},{"id":2316626,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-28T19:24:36.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":22140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of November 17, 2021 (the \"Vesting Commencement Date\") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":22140,"derivative":{"exercise_price":3.03,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":22140},"source":{"system":"sec-edgar","filing":"0000899243-22-012466","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000089924322012466/doc4.xml","form_type":"4"}},{"id":2502863,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-19T22:28:19.000Z","date":"2021-11-17","kind":"grant","acquired":true,"shares":27860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of November 17, 2021 (the \"Vesting Commencement Date\") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer."}],"balance_after":27860,"derivative":{"exercise_price":9.01,"expiration_date":"2031-11-16","underlying":"Common Stock","underlying_shares":27860},"source":{"system":"sec-edgar","filing":"0001209191-21-065887","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1641281/000120919121065887/doc4.xml","form_type":"4"}},{"id":2611365,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":39271,"kind":"person","name":"O'CALLAGHAN BRIAN","position":1,"cik":"0001415015","reported_name":"O'CALLAGHAN BRIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-06T21:00:59.000Z","date":"2021-08-04","kind":"grant","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable on August 4, 2022."}],"balance_after":13750,"derivative":{"exercise_price":8.87,"expiration_date":"2031-08-04","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001493152-21-018903","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1415015/000149315221018903/ownership.xml","form_type":"4"}}]}